Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphomas and oncolytic virus therapy.

Tommy Alain1, Chandini Thirukkumaran, Donald G Morris

  • 1Cancer Biology Research Group, University of Calgary, Alberta, Canada. talain@ucalgary.ca

Clinical Lymphoma
|October 15, 2003
PubMed
Summary

Oncolytic viruses, capable of targeting and destroying cancer cells, offer a promising avenue for treating leukemias and lymphomas. Modern research aims to harness these viruses for effective cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-Dose Ionizing Radiation Modulates Translation Efficiency in Human Lung Fibroblasts.

Radiation research·2026
Same author

Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Low-Dose Ionizing Radiation Modulates Translation Efficiency in Human Lung Fibroblasts.

Radiation research·2026
Same author

Enhanced glioblastoma immunotherapy via SMAC mimetic dose escalation and TGFβ blockade.

Neuro-oncology advances·2026
Same author

RSK1 and RSK2 modulate the translatome of glioblastoma cells in an isoform-specific and mTORC1 independent manner.

Neuro-oncology advances·2025
Same author

Reovirus oncolysis and the next frontiers for this unique oncoviral immunotherapy.

Seminars in immunology·2025

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Spontaneous remission of leukemias and lymphomas has been observed following natural viral infections.
  • Early attempts at viral oncolysis yielded limited success due to technological constraints.

Purpose of the Study:

  • To review current knowledge on oncolytic viruses for lymphoma treatment.
  • To explore the potential of oncolytic virotherapy in cancer remission.

Main Methods:

  • Review of medical literature on viral infections and cancer remission.
  • Analysis of historical and modern research on oncolytic viruses.
  • Focus on viruses with demonstrated oncolytic properties.

Main Results:

  • Documented cases of leukemia and lymphoma remission linked to viral infections.

Related Experiment Videos

  • Identification of viruses with distinct oncolytic capabilities.
  • Advancements in technology and understanding of cancer biology.

    • Conclusions:

    • Oncolytic virotherapy holds significant promise for future cancer treatment strategies.
    • Modern approaches are expected to yield more efficient oncolytic viral therapies.
    • Further research is warranted to optimize oncolytic virus applications in lymphoma treatment.